64 related articles for article (PubMed ID: 20308647)
1. Evaluating enzyme replacement therapy in fabry disease.
Koskenvuo JW; Kantola IM
Arch Intern Med; 2010 Mar; 170(6):573-4; author reply 574. PubMed ID: 20308647
[No Abstract] [Full Text] [Related]
2. Cardiovascular events in patients with fabry disease natural history data from the fabry registry.
Patel MR; Cecchi F; Cizmarik M; Kantola I; Linhart A; Nicholls K; Strotmann J; Tallaj J; Tran TC; West ML; Beitner-Johnson D; Abiose A
J Am Coll Cardiol; 2011 Mar; 57(9):1093-9. PubMed ID: 21349401
[TBL] [Abstract][Full Text] [Related]
3. Fabry disease manifesting as chronic uveitis--treated with enzyme replacement therapy.
Shen YD; Yang CM; Huang JS
Eye (Lond); 2007 Mar; 21(3):431-2. PubMed ID: 16858434
[No Abstract] [Full Text] [Related]
4. Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment.
Weidemann F; Niemann M; Breunig F; Herrmann S; Beer M; Störk S; Voelker W; Ertl G; Wanner C; Strotmann J
Circulation; 2009 Feb; 119(4):524-9. PubMed ID: 19153271
[TBL] [Abstract][Full Text] [Related]
5. Fabry disease with aortic regurgitation.
Choi S; Seo H; Park M; Kim J; Hwang S; Kwon K; Her K; Won Y
Ann Thorac Surg; 2009 Feb; 87(2):625-8. PubMed ID: 19161799
[TBL] [Abstract][Full Text] [Related]
6. Enzyme replacement therapy in severe Fabry disease with renal failure: a 1-year follow-up.
Tsambaos D; Chroni E; Manolis A; Monastirli A; Pasmatzi E; Sakkis T; Davlouros P; Goumenos D; Katrivanou A; Georgiou S
Acta Derm Venereol; 2004; 84(5):389-92. PubMed ID: 15370707
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic goals in the treatment of Fabry disease.
Mehta A; West ML; Pintos-Morell G; Reisin R; Nicholls K; Figuera LE; Parini R; Carvalho LR; Kampmann C; Pastores GM; Lidove O
Genet Med; 2010 Nov; 12(11):713-20. PubMed ID: 20975569
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of the cardiovascular consequences of Fabry disease.
Baig S; Vijapurapu R; Alharbi F; Nordin S; Kozor R; Moon J; Bembi B; Geberhiwot T; Steeds RP
QJM; 2019 Jan; 112(1):3-9. PubMed ID: 29878206
[TBL] [Abstract][Full Text] [Related]
9. Fabry disease: clinical spectrum and evidence-based enzyme replacement therapy.
Desnick RJ; Banikazemi M
Nephrol Ther; 2006 Jan; 2 Suppl 2():S172-85. PubMed ID: 17373219
[TBL] [Abstract][Full Text] [Related]
10. Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy.
Breunig F; Wanner C
J Nephrol; 2008; 21(1):32-7. PubMed ID: 18264934
[TBL] [Abstract][Full Text] [Related]
11. Enzyme replacement therapy for Fabry disease: morphologic and histochemical changes in the urinary sediments.
Utsumi K; Mitsuhashi F; Asahi K; Sakurazawa M; Arii K; Komaba Y; Katsumata T; Katsura K; Kase R; Katayama Y
Clin Chim Acta; 2005 Oct; 360(1-2):103-7. PubMed ID: 16112661
[TBL] [Abstract][Full Text] [Related]
12. Fabry Disease: An Uncommon Cause of Renal Failure.
López PD; Andreias L; Astiazarán-Symonds E; Chalabi J
Am J Med; 2017 Sep; 130(9):e389-e390. PubMed ID: 28389313
[No Abstract] [Full Text] [Related]
13. Fabry nephropathy and the case for adjunctive renal therapy.
Wanner C; Breunig F
J Am Soc Nephrol; 2007 Sep; 18(9):2426-8. PubMed ID: 17699807
[No Abstract] [Full Text] [Related]
14. Fabry disease: case report with emphasis on enzyme replacement therapy and possible future therapeutic options.
Möhrenschlager M; Pontz BF; Lanzl I; Podskarbi T; Henkel V; Ring J
J Dtsch Dermatol Ges; 2007 Jul; 5(7):594-7. PubMed ID: 17610610
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of uncontrolled hypertension in patients with Fabry disease.
Kleinert J; Dehout F; Schwarting A; de Lorenzo AG; Ricci R; Kampmann C; Beck M; Ramaswami U; Linhart A; Gal A; Houge G; Widmer U; Mehta A; Sunder-Plassmann G
Am J Hypertens; 2006 Aug; 19(8):782-7. PubMed ID: 16876675
[TBL] [Abstract][Full Text] [Related]
16. [Fabry disease].
Feriozzi S; Faraggiana T
G Ital Nefrol; 2005; 22 Suppl 33():S34-8. PubMed ID: 16419004
[TBL] [Abstract][Full Text] [Related]
17. Cystatin C as a marker of early changes of renal function in Fabry nephropathy.
Feriozzi S; Germain DP; Di Vito R; Legrand A; Ricci R; Barbey F
J Nephrol; 2007; 20(4):437-43. PubMed ID: 17879210
[TBL] [Abstract][Full Text] [Related]
18. Diagnosing Fabry disease--delays and difficulties within discordant siblings.
Brady M; Montgomery E; Brennan P; Mohindra R; Sayer JA
QJM; 2015 Jul; 108(7):585-90. PubMed ID: 23378663
[No Abstract] [Full Text] [Related]
19. Progression of Fabry cardiomyopathy despite enzyme replacement therapy.
Pieroni M; Camporeale A; Della Bona R; Sabini A; Cosmi D; Magnolfi A; Bolognese L
Circulation; 2013 Oct; 128(15):1687-8. PubMed ID: 24100483
[No Abstract] [Full Text] [Related]
20. Fabry disease: treatment and diagnosis.
Rozenfeld PA
IUBMB Life; 2009 Nov; 61(11):1043-50. PubMed ID: 19859978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
